Sign in
NTRA-NATERA INC

Natera Surges 22.3% After Reporting Strong Q3 Results and Optimistic 2024 Revenue Forecast, Prompting Analysts to Raise Price Targets

Monday

18 November, 2024

Natera's recent Q3 results have sparked excitement, showcasing a narrower loss and impressive sales of $439.8 million, exceeding expectations. With a bullish 2024 revenue forecast that outstrips market estimates, can Natera maintain this momentum in a competitive healthcare landscape?

article image for NTRA

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
96
Key Takeaways
  • Natera reported better-than-anticipated financial results for Q3 2023, with sales reaching $439.8 million.
  • The company provided a positive revenue forecast for 2024, projecting $1.61 to $1.64 billion.
  • Following the earnings report, Natera's stock price increased by over 20%.
  • Analysts are optimistic, raising price targets and indicating strong confidence in Natera's future.
  • CEO Steve Chapman emphasizes patient care and growth, enhancing the company's investment appeal.
More on NATERA INC
Read more insights on NATERA INC

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.